Global Strategy Fund REGN Holdings History
Global Strategy Fund's Regeneron Pharmaceuticals Inc Holding Summary
As of 2025-02-28, VALIC Co I held 181.00 shares of Regeneron Pharmaceuticals Inc(REGN), totaling $126,470.00. This investment constitutes 0.1% of their stock portfolio, and VALIC Co I now holds 0% of the outstanding Regeneron Pharmaceuticals Inc(REGN) stock.
The initial trade took place in 2022Q1. And since then Global Strategy Fund has made 2 purchases of REGN, at an average price of $626.40, for a total of 2,626.00 shares. In addition, there have been 9 sales at an average price of $869.50 for 2,445.00 shares. Based on historical transaction data and REGN's current price of $567.74, Global Strategy Fund's estimated gain on his REGN holdings is $583,750.68, reflecting a 35.49% gain to date.
Global Strategy Fund REGN ($567.74) Holding Chart
Global Strategy Fund REGN ($567.74) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
